Dermapharm Holding slips after outlook misses expectations

Dermapharm Holding SE

29/03/2022 09:52

** Shares of Germany's Dermapharm Holding  DMPG.DE  slide 4%
after the dermatology drugmaker's outlook missed expectations 
    ** Dermapharm said it expects 2022 revenue to grow 10-13%
y/y, while adj. EBITDA 3-7% y/y
    ** Stifel says sales guidance is 4% below consensus and 7%
below adj. EBITDA consensus at the mid-point
    ** The stock is among the worst performers on the German
small-cap index  .SDAXI 


 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))